Volume 147, Issue 1, Pages 3-10 (October 2017)

Slides:



Advertisements
Similar presentations
Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr
Advertisements

Nuclear Receptors, RXR, and the Big Bang Ronald M. Evans, David J. Mangelsdorf Cell Volume 157, Issue 1, Pages (March 2014) DOI: /j.cell
The Landscape of Microsatellite Instability in Colorectal and Endometrial Cancer Genomes Tae-Min Kim, Peter W. Laird, Peter J. Park Cell Volume 155, Issue.
Analysis of health stories in daily newspapers in the UK A. Robinson, A. Coutinho, A. Bryden, M. McKee Public Health Volume 127, Issue 1, Pages (January.
ABO-incompatible kidney transplantation Kota Takahashi, Kazuhide Saito Transplantation Reviews Volume 27, Issue 1, Pages 1-8 (January 2013) DOI: /j.trre
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm Thierry Soussi, Klas G. Wiman Cancer Cell Volume 12, Issue 4, Pages (October.
Professionalism and the work-life balance Thomas S. Huber, MD, PhD Journal of Vascular Surgery Volume 60, Issue 4, Pages (October 2014) DOI:
Small-Cell Carcinoma in Association With a Mature Cystic Teratoma of the Ovary: A Case Report With Literature Review Karina E. Hew, Kimberley Studeman,
Volume 144, Issue 1, Pages (January 2017)
A technicians' perspective: tips and techniques for using disposable tab electrocardiogram electrodes; an easy to remember method for preventing electrocardiogram.
A New Model for Imaging and Radiation Therapy Quality Assurance in the National Clinical Trials Network of the National Cancer Institute  Thomas J. FitzGerald,
Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade.
Volume 146, Issue 2, Pages (August 2017)
Volume 148, Issue 1, Pages (January 2018)
Preface Surgical Oncology Clinics
Rajmohan Murali, Rachel N. Grisham, Robert A. Soslow 
Are patients willing to travel for better ovarian cancer care?
Volume 148, Issue 1, Pages (January 2018)
Volume 148, Issue 1, Pages (January 2018)
Volume 146, Issue 3, Pages (September 2017)
Preface Clinics in Perinatology
Volume 145, Issue 2, Pages (May 2017)
Vulvar intraepithelial neoplasia: Risk factors for recurrence
Corrigendum to “MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer” [Gynecologic Oncology 110: 13–21, 2008]  Douglas.
Volume 141, Issue 1, Pages 2-9 (April 2016)
The efficacy of mTORC1/2 inhibition on ovarian cancer stem cells
M. Ulm, D. Lee, A.R. Mabe, M.P. Lowe, S. Kumar, T. Tillmanns
A Comparison of Quality-of-Life Domains and Clinical Factors in Ovarian Cancer Patients: A Gynecologic Oncology Group Study  Vivian E. von Gruenigen,
Volume 151, Issue 1, Pages (October 2018)
Wilberto Nieves-Neira, J. Julie Kim, Daniela Matei 
Clinical Neurology Veterinary Clinics: Equine Practice
Volume 142, Issue 3, Pages (September 2016)
Databases for Clinical Research
Pathologic response at interval debulking surgery following neoadjuvant chemotherapy predicts improved survival in women with ovarian cancer  E.N. Prendergast,
K. Bixel, N. Denlinger, L. Marsh, A. Quick, R. Salani
Volume 152, Issue 1, Pages (January 2019)
Laparoscopic staging for stage I epithelial ovarian cancer: Analysis of the National Cancer Data Base  A. Melamed, J.T. Clemmer, N.L. Keating, J.D. Wright,
The origins of multidisciplinary cancer care
Adherence to hematologic hold parameters in dose-dense chemotherapy for ovarian malignancies: A survey of the National Comprehensive Cancer Network (NCCN)
Confessions of a journal junkie
I. Mert, A. R. Munkarah, R. K. Hanna, J. Chhina, M. S. Carey, M
Survivors' acceptance of treatment side effects evolves as goals of care change over the cancer continuum  A. Ellis, M.K. Frey, L.M. Koontz, S. Shyne,
Volume 152, Issue 1, Pages (January 2019)
Are ovarian cancer debulking models reliable: Variance and predictability are dependent on institutional optimal debulking rates  N.A. Latif, E.M. Ko,
Volume 152, Issue 1, Pages (January 2019)
Volume 147, Issue 1, Pages (October 2017)
Limited access safety lead-in of the MEK inhibitor trametinib in combination with GSK , an AKT inhibitor, in patients with recurrent or persistent.
Volume 4, Issue 5, Pages 2-3 (October 2006)
Clinical Snippets Journal of Investigative Dermatology
Gender-Variant Children and Transgender Adolescents
Volume 142, Issue 2, Pages (August 2016)
Annika Idahl, Andrea Hermansson, Ann Lalos  Gynecologic Oncology 
Volume 147, Issue 3, Pages (December 2017)
Volume 152, Issue 1, Pages (January 2019)
Volume 130, Issue 1, Pages (July 2013)
Treatment of Colorectal Cancer
Volume 151, Issue 1, Pages (October 2018)
Upregulated Wnt signaling is associated with increased survival of patients with high- grade serous ovarian cancer  M. Dandapani, B.L. Seagle, R. Samuelson,
Erratum to “Aurora-A overexpression and aneuploidy predict poor outcome in serous ovarian carcinoma” [Gynecol Oncol. 120 (2011) 11–17]  Heini Lassus,
Volume 52, Issue 4, Pages xi-xii (October 2008)
Volume 152, Issue 1, Pages (January 2019)
Volume 152, Issue 1, Pages (January 2019)
Volume 147, Issue 3, Pages (December 2017)
Volume 152, Issue 1, Pages (January 2019)
To Infinium, and Beyond! Cancer Cell
Should ovarian preservation be considered for women younger than 60 years with endometrial carcinoma?  L.M. Bean, K. Taylor, K.M. Anderson, M.A. Davis,
A Comparison of Quality-of-Life Domains and Clinical Factors in Ovarian Cancer Patients: A Gynecologic Oncology Group Study  Vivian E. von Gruenigen,
Volume 115, Issue 1, Pages (October 2009)
David Hubel and Torsten Wiesel
Volume 153, Issue 3, Pages (June 2019)
Presentation transcript:

Volume 147, Issue 1, Pages 3-10 (October 2017) FDA ovarian cancer clinical trial endpoints workshop: A Society of Gynecologic Oncology White Paper  Thomas J. Herzog, Gwynn Ison, Ronald D. Alvarez, Sanjeeve Balasubramaniam, Deborah K. Armstrong, Julia A. Beaver, Annie Ellis, Shenghui Tang, Peg Ford, Amy McKee, David M. Gershenson, Geoffrey Kim, Bradley J. Monk, Richard Pazdur, Robert L. Coleman  Gynecologic Oncology  Volume 147, Issue 1, Pages 3-10 (October 2017) DOI: 10.1016/j.ygyno.2017.08.012 Copyright © 2017 Elsevier Inc. Terms and Conditions

Fig. 1 Frequent mutational alterations in different ovarian cancer histological subtypes. Gynecologic Oncology 2017 147, 3-10DOI: (10.1016/j.ygyno.2017.08.012) Copyright © 2017 Elsevier Inc. Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.